Abivax (2X1.F) Stock Highlights

9.27 | +0.65%

2024-10-29 04:10:52

Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The antiviral and immunotherapeutic products that the group develops result from three technology platforms; a Modulation of RNA Biogenesis platform, an Immune stimulation platform, and a Polyclonal antibody platform. The Antiviral platform targets the formation of Ribonucleoproteins in the nucleus or the cytoplasm of the infected cell during viral infection, Immune stimulation platform focuses on invariant natural killer agonists and Polyclonal antibodies platform generates neutralizing antibodies against different viruses. Its current pipeline includes ABX464 for Ulcerative Colitis and ABX196 for Hepatocellular Carcinoma.

Statistics

Range Today

9.27 9.27

Volume Today 500

Range 1 Year

8.04 15.26

Volume 1 Year 15.63K

Range 3 Year

5.55 29.5

Volume 3 Year 73.33K

Range 10 Year

5.29 36.65

Volume 10 Year 551.73K

Highlights

Market Capitalization 650.02M (small)

Floating Shares 26.15M

Current Price 9.27

Price To Earnings -2.71

Price To Revenue 52.1

Price To Book 4.58

Earnings Per Share -3.43

Payout Ratio 0%

Performance

Latest +0.65%

1 Month -7.49%

3 Months -16.49%

6 Months -36.51%

1 Year +7.79%

3 Years -67.53%

5 Years +1.2%

10 Years -46.26%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.